Brief Article
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 28, 2014; 20(4): 1038-1047
Published online Jan 28, 2014. doi: 10.3748/wjg.v20.i4.1038
Table 3 Number of colonoscopies needed to detect one lesion and cost per lesion (€) according to positivity threshold and fecal immunochemical test testing strategy
LesionPositivity threshold (ng/mL)No. need to scope
Cost per lesion detected (€)
Cost increment (€)
FIT1FITmaxFIT1FITmax
CRC0155.8016898
5013.4020.202206348958.16
7512.2017.802038322358.15
10011.0016.401912305559.78
11510.2015.801814298564.55
15012.0017.502163345159.55
20011.2514.752075308348.58
Advanced neoplasia108.20889
50 1.97 2.4631742534.07
75 1.91 2.2831241332.37
100 1.77 2.2830242440.40
115 1.76 2.2630642639.22
150 1.78 2.2631244542.63
200 1.67 2.1931145646.62

  • Citation: Hernandez V, Cubiella J, Gonzalez-Mao MC, Iglesias F, Rivera C, Iglesias MB, Cid L, Castro I, Castro L, Vega P, Hermo JA, Macenlle R, Martínez-Turnes A, Martínez-Ares D, Estevez P, Cid E, Vidal MC, López-Martínez A, Hijona E, Herreros-Villanueva M, Bujanda L, investigators JIRPTCS. Fecal immunochemical test accuracy in average-risk colorectal cancer screening. World J Gastroenterol 2014; 20(4): 1038-1047
  • URL: https://www.wjgnet.com/1007-9327/full/v20/i4/1038.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v20.i4.1038